<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oncology Product Guide &#187; pemetrexed</title>
	<atom:link href="http://www.oncologyproductguide.com/blog/tag/pemetrexed/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.oncologyproductguide.com/blog</link>
	<description>A comprehensive guide to oncology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 12:00:01 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Alimta approved by FDA</title>
		<link>http://www.oncologyproductguide.com/blog/2009/07/16/alimta-approved-by-fda/</link>
		<comments>http://www.oncologyproductguide.com/blog/2009/07/16/alimta-approved-by-fda/#comments</comments>
		<pubDate>Thu, 16 Jul 2009 07:31:17 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[Treatments]]></category>
		<category><![CDATA[advanced lung cancer]]></category>
		<category><![CDATA[Alimta]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[maintenance therapy]]></category>
		<category><![CDATA[metastatic lung cancer]]></category>
		<category><![CDATA[pemetrexed]]></category>

		<guid isPermaLink="false">http://www.oncologyproductguide.com/blog/2009/07/16/alimta-approved-by-fda/</guid>
		<description><![CDATA[The FDA has approved Alimta, the first drug for maintenance therapy of advanced or metastatic lung cancer. Manufactured by Eli Lilly and generically known as pemetrexed, this drug may prevent this form of lung cancer from progressing further after the size of the tumor has shrunk or been stabilized following chemotherapy. Alimta works by disrupting [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.oncologyproductguide.com/blog/wp-content/uploads/2009/07/alimta.png" align="left" height="129" width="200" vspace="5" hspace="5" />The FDA has approved Alimta, the first drug for maintenance therapy of advanced or metastatic lung cancer. Manufactured by Eli Lilly and generically known as pemetrexed, this drug may prevent this form of lung cancer from progressing further after the size of the tumor has shrunk or been stabilized following chemotherapy. Alimta works by disrupting metabolic processes which depend on the B-vitamin folate for cell replication.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.oncologyproductguide.com/blog/2009/07/16/alimta-approved-by-fda/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
